Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea
· Delayed Price · Currency is KRW 1,614.00
-1.00 (-0.06%)
At close: Dec 5, 2025
Kangstem Biotech Revenue
Kangstem Biotech had revenue of 783.33M KRW in the quarter ending September 30, 2024, a decrease of -39.10%. This brings the company's revenue in the last twelve months to 12.77B, up 30.25% year-over-year. In the year 2023, Kangstem Biotech had annual revenue of 12.70B, down -22.06%.
Revenue (ttm)
12.77B
Revenue Growth
+30.25%
P/S Ratio
11.88
Revenue / Employee
131.70M
Employees
97
Market Cap
151.80B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |